Could one drug replace many for kidney transplant patients?
NCT ID NCT04786067
Summary
This study tested whether kidney transplant patients could safely switch from taking several anti-rejection medications to just one drug called belatacept. Researchers used special blood tests to monitor patients for signs of organ rejection during this medication change. The goal was to see if this simpler treatment plan could control the immune system effectively while reducing side effects from multiple drugs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT IMMUNOSUPPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UT Southwestern Medical Center
Dallas, Texas, 75390, United States
Conditions
Explore the condition pages connected to this study.